Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, which develops in the context of fibrosis and cirrhosis caused by chronic inflammation, in turn due to non-alcoholic fatty liver disease (NAFLD), alcohol consumption and/or hepatitis viral infection. An increased number of senescent cells are associated with age-related tissue degeneration during NAFLD-induced HCC, or during chemotherapeutic treatment. Senolytic agents target selectively senescent cells. A combination of the senolytic drugs dasatinib and quercetin (D+Q) reduced hepatic lipid accumulation and alleviated age-associated physical dysfunction in mice. However, whether D+Q can impact the treatment of HCC, at the end-stage of the NAFLD inflammatory spectrum, is unknown. Here, using two well-established HCC cell lines (HepG2, Huh-7), we demonstrate that the maximal cytostatic doses for D and/or Q (1 + 1 μM) lacked efficacy in removing doxorubicin-induced β-gal-positive senescent cells. Moreover, D+Q did not affect doxorubicin-dependent induction of flattened morphology, activation of p16, expression of SASP-associated genes or formation of γH2AX foci. We then investigated the antitumor efficacy of doxorubicin, D+Q, or the combination, in xenograft studies conducted with HCC cells inoculated in athymic nude mice. Doxorubicin reduced tumor growth by 30% compared to control mice, while D+Q was ineffective in synergizing with doxorubicin and in clearing doxorubicin-induced HCC senescent cells. Unexpectedly, D+Q alone appeared to have acute pro-tumorigenic effects in control mice. While our data need to be confirmed in animal models that fully recapitulate NAFLD, we demonstrate that these compounds are ineffective, alone or in synergy with senescence-inducing chemotherapy, against experimental HCC.

Department of Chemistry and Biotechnology Tallinn University of Technology Tallinn Estonia

Division of Medicine Institute for Liver and Digestive Health University College London London United Kingdom

Faculty of Medicine and Dentistry Institute of Molecular and Translational Medicine Palacky University Olomouc Czechia

Genome Integrity Unit Danish Cancer Society Research Center Copenhagen Denmark

International Clinical Research Center Brno Czechia

IVEX Lab Tallinn Estonia

Science for Life Laboratory Division of Translational Medicine and Chemical Biology Department of Medical Biochemistry and Biophysics Karolinska Institute Solna Sweden

See more in PubMed

Gores GJ. Decade in review-hepatocellular carcinoma: HCC-subtypes, stratification and sorafenib. Nat Rev Gastroenterol Hepatol. (2014) 11:645–7. 10.1038/nrgastro.2014.157 PubMed DOI PMC

Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, et al. . Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA (2010) 304:2154–60. 10.1001/jama.2010.1672 PubMed DOI

Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. (2018) 15:599–616. 10.1038/s41571-018-0073-4 PubMed DOI

Yang JD, Altekruse SF, Nguyen MH, Gores GJ, Roberts LR. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer (2017) 123:81–9. 10.1002/cncr.30246 PubMed DOI PMC

Loaiza N, Demaria M. Cellular senescence and tumor promotion: is aging the key? Biochim Biophys Acta (2016) 1865:155–67. 10.1016/j.bbcan.2016.01.007 PubMed DOI

Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD. The clinical potential of senolytic drugs. J Am Geriatr Soc. (2017) 65:2297–301. 10.1111/jgs.14969 PubMed DOI PMC

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, et al. . DNA hypomethylation and histone variant macroh2a1 synergistically attenuate chemotherapy-induced senescence to promote hepatocellular carcinoma progression. Cancer Res. (2016) 76:594–606. 10.1158/0008-5472.CAN-15-1336 PubMed DOI PMC

Aravinthan AD, Alexander GJM. Senescence in chronic liver disease: is the future in aging? J Hepatol. (2016) 65:825–34. 10.1016/j.jhep.2016.05.030 PubMed DOI

Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, et al. . Cellular senescence drives age-dependent hepatic steatosis. Nat Commun. (2017) 8:15691. 10.1038/ncomms15691 PubMed DOI PMC

Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. . Senolytics improve physical function and increase lifespan in old age. Nat Med. (2018) 24:1246–56. 10.1038/s41591-018-0092-9 PubMed DOI PMC

Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, et al. . Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. (2017) 8:14532. 10.1038/ncomms14532 PubMed DOI PMC

Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, et al. . Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. (2009) 50:1132–41. 10.1016/j.jhep.2009.01.027 PubMed DOI

Vinciguerra M, Sgroi A, Veyrat-Durebex C, Rubbia-Brandt L, Buhler LH, Foti M. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology (2009) 49:1176–84. 10.1002/hep.22737 PubMed DOI

Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. Gastroenterology (2008) 134:268–80. 10.1053/j.gastro.2007.10.010 PubMed DOI

Lo Re O, Fusilli C, Rappa F, Van Haele M, Douet J, Pindjakova J, et al. . Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma. Hepatology (2017) 67:636–50. 10.1002/hep.29519 PubMed DOI

Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, et al. . Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. Epigenetics (2016) 11:709–20. 10.1080/15592294.2016.1214781 PubMed DOI PMC

Weiland T, Lampe J, Essmann F, Venturelli S, Berger A, Bossow S, et al. . Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses. Int J Cancer (2014) 134:235–43. 10.1002/ijc.28350 PubMed DOI

Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC. J Surg Res. (2008) 150:219–26. 10.1016/j.jss.2008.01.029 PubMed DOI

Zhang X, Wu X, Tang W, Luo Y. Loss of p16(Ink4a) function rescues cellular senescence induced by telomere dysfunction. Int J Mol Sci. (2012) 13:5866–77. 10.3390/ijms13055866 PubMed DOI PMC

Kilic Eren M, Kilincli A, Eren O. Resveratrol induced premature senescence is associated with DNA damage mediated SIRT1 and SIRT2 down-regulation. PLoS ONE (2015) 10:e0124837. 10.1371/journal.pone.0124837 PubMed DOI PMC

Rappa F, Greco A, Podrini C, Cappello F, Foti M, Bourgoin L, et al. . Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma. PLoS ONE (2013) 8:e54458. 10.1371/journal.pone.0054458 PubMed DOI PMC

Enos RT, Velazquez KT, Carson MS, McClellan JL, Nagarkatti P, Nagarkatti M, et al. . A low dose of dietary quercetin fails to protect against the development of an obese phenotype in mice. PLoS ONE (2016) 11:e0167979. 10.1371/journal.pone.0167979 PubMed DOI PMC

Luker KE, Pata P, Shemiakina II, Pereverzeva A, Stacer AC, Shcherbo DS, et al. . Comparative study reveals better far-red fluorescent protein for whole body imaging. Sci Rep. (2015) 5:10332. 10.1038/srep10332 PubMed DOI PMC

Noppe G, Dekker P, de Koning-Treurniet C, Blom J, van Heemst D, Dirks RW, et al. . Rapid flow cytometric method for measuring senescence associated beta-galactosidase activity in human fibroblasts. Cytometry A (2009) 75:910–6. 10.1002/cyto.a.20796 PubMed DOI

Podrini C, Koffas A, Chokshi S, Vinciguerra M, Lelliott CJ, White JK, et al. . MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis. FASEB J. (2015) 29:1676–87. 10.1096/fj.14-262717 PubMed DOI

Histone Variant macroH2A1.1 Enhances Nonhomologous End Joining-dependent DNA Double-strand-break Repair and Reprogramming Efficiency of Human iPSCs

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin

Senescence-like phenotype in post-mitotic cells of mice entering middle age

Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activation

Obesity-induced nucleosome release predicts poor cardio-metabolic health

Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation